Related Experiment Videos
The Epstein-Barr virus receptor on two nasopharyngeal carcinoma model cell lines
T Takimoto1, R Umeda, R Glaser
1Department of Otolaryngology, School of Medicine, Kanazawa University, Japan.
Abstract:
It was reported that the OKB7 monoclonal antibody to C3d receptor could directly inhibit Epstein-Barr virus (EBV) attachment to and infection of B-lymphocytes. So we tested whether the OKB7 could inhibit superinfection of two epithelial NPC model cell lines (D98/HR-1 and NPC-KT) with EBV. Pretreatment of B-lymphocytes with the OKB7 significantly inhibits EBV infection. However, pretreatment with the OKB7 had no effect on superinfection of D98/HR-1 and NPC-KT cells. These data suggest that an EBV receptor, unrelated to C3d receptor, exists.
Insights
The OKB7 antibody inhibits Epstein-Barr virus (EBV) infection in B-lymphocytes but not in epithelial NPC cells. This suggests EBV uses a different receptor on epithelial cells, distinct from the C3d receptor found on B-lymphocytes.
Area of Science:
- Virology
- Immunology
- Cell Biology
Background:
- Epstein-Barr virus (EBV) infects B-lymphocytes by attaching to the C3d receptor.
- The OKB7 monoclonal antibody targets the C3d receptor and has shown inhibitory effects on EBV infection in B-lymphocytes.
Purpose of the Study:
- To investigate whether the OKB7 antibody could inhibit EBV superinfection in epithelial cells relevant to nasopharyngeal carcinoma (NPC).
- To determine if the C3d receptor is involved in EBV entry into epithelial NPC cell lines.
Main Methods:
- Treatment of epithelial NPC cell lines (D98/HR-1 and NPC-KT) with the OKB7 antibody.
- Exposure of pretreated cells to EBV to assess superinfection rates.
- Comparison of EBV infection inhibition in B-lymphocytes versus epithelial NPC cells.
Main Results:
- Pretreatment of B-lymphocytes with OKB7 significantly inhibited EBV infection, confirming previous findings.
- Pretreatment of D98/HR-1 and NPC-KT epithelial cells with OKB7 had no effect on EBV superinfection.
- These results indicate that EBV entry into epithelial NPC cells is not mediated by the C3d receptor.
Conclusions:
- EBV utilizes a receptor unrelated to the C3d receptor for attachment and infection of epithelial NPC cells.
- The findings highlight a potential difference in EBV entry mechanisms between B-lymphocytes and epithelial cells.
- This suggests distinct viral-host interactions in EBV pathogenesis, particularly in nasopharyngeal carcinoma development.